- Home
- GWRS vs SOPH Comparison
GWRS vs SOPH Comparison
Compare GWRS & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRS
- SOPH
- Stock Information
- Founded
- GWRS 2003
- SOPH 2011
- Country
- GWRS United States
- SOPH Switzerland
- Employees
- GWRS N/A
- SOPH N/A
- Industry
- GWRS Water Supply
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GWRS Utilities
- SOPH Health Care
- Exchange
- GWRS Nasdaq
- SOPH Nasdaq
- Market Cap
- GWRS 288.9M
- SOPH 247.0M
- IPO Year
- GWRS 2010
- SOPH 2021
- Fundamental
- Price
- GWRS $12.89
- SOPH $3.37
- Analyst Decision
- GWRS
- SOPH Strong Buy
- Analyst Count
- GWRS 0
- SOPH 3
- Target Price
- GWRS N/A
- SOPH $7.00
- AVG Volume (30 Days)
- GWRS 18.8K
- SOPH 21.8K
- Earning Date
- GWRS 11-06-2024
- SOPH 11-05-2024
- Dividend Yield
- GWRS 2.33%
- SOPH N/A
- EPS Growth
- GWRS N/A
- SOPH N/A
- EPS
- GWRS 0.26
- SOPH N/A
- Revenue
- GWRS $52,020,000.00
- SOPH $64,938,000.00
- Revenue This Year
- GWRS $2.72
- SOPH $7.70
- Revenue Next Year
- GWRS $3.56
- SOPH $20.61
- P/E Ratio
- GWRS $50.29
- SOPH N/A
- Revenue Growth
- GWRS 5.90
- SOPH 20.14
- 52 Week Low
- GWRS $9.34
- SOPH $2.70
- 52 Week High
- GWRS $13.42
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- GWRS 56.28
- SOPH 43.13
- Support Level
- GWRS $12.75
- SOPH $3.30
- Resistance Level
- GWRS $13.30
- SOPH $3.66
- Average True Range (ATR)
- GWRS 0.28
- SOPH 0.20
- MACD
- GWRS 0.09
- SOPH 0.01
- Stochastic Oscillator
- GWRS 68.46
- SOPH 53.97
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operate within the State of Arizona.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.